United States

OxySure Therapeutics Inc (OXYS)

Track

OxySure Therapeutics Inc. has not recorded any insider trading activity within the last three months. The most recent transactions occurred in August 2015, when insiders, including CEO Julian T. Ross and Thomas Cox, executed multiple buy orders for company shares. Prior to these acquisitions, the last recorded activity was a sale by the CEO in February 2013.
Ticker: OXYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
COX THOMAS Non-Executive Director
Transaction date
Purchase
Price
40.53
Quantity 29,190 +17.1%
Value US$4,135,048
Ross Julian T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
250.53
Quantity 33,160 -24.3%
Value US$4,937,571
Ross Julian T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
397.59
Quantity 55,594 -0.6%
Value US$2,657,888
Ross Julian T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.50
Quantity 10,200 +6.5%
Value US$5,054
Ross Julian T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.66
Quantity 4,500 +2.9%
Value US$2,980
Ross Julian T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.69
Quantity 2,000 +1.3%
Value US$1,385
Ross Julian T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.68
Quantity 5,100 +3.5%
Value US$3,481
Ross Julian T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.67
Quantity 15,000 +0.1%
Value US$10,042
Ross Julian T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.67
Quantity 2,800 +2.0%
Value US$1,875
Ross Julian T CEO, PRESIDENT, SECRETARY Executive Director Large shareholder
Transaction date
Sale
Price
0.63
Quantity 50,000 -0.3%
Value US$31,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-08-14 2015-08-12 B Purchase COX THOMAS Non-Executive Director
29,190 +17.1%
40.53
US$4,135,048 		29,190 +17.1% 40.53 US$4,135,048
2015-08-14 2015-08-04 B Purchase Ross Julian T

CEO

Executive Director Large shareholder
33,160 -24.3%
250.53
US$4,937,571 		33,160 -24.3% 250.53 US$4,937,571
2015-07-29 2015-07-29 B Purchase Ross Julian T

CEO

Executive Director Large shareholder
55,594 -0.6%
397.59
US$2,657,888 		55,594 -0.6% 397.59 US$2,657,888
2015-07-24 2015-07-23 B Purchase Ross Julian T

CEO

Executive Director Large shareholder
10,200 +6.5%
0.50
US$5,054 		10,200 +6.5% 0.50 US$5,054
2015-06-04 2015-06-04 B Purchase Ross Julian T

CEO

Executive Director Large shareholder
4,500 +2.9%
0.66
US$2,980 		4,500 +2.9% 0.66 US$2,980
2015-05-29 2015-05-28 B Purchase Ross Julian T

CEO

Executive Director Large shareholder
2,000 +1.3%
0.69
US$1,385 		2,000 +1.3% 0.69 US$1,385
2015-05-27 2015-05-27 B Purchase Ross Julian T

CEO

Executive Director Large shareholder
5,100 +3.5%
0.68
US$3,481 		5,100 +3.5% 0.68 US$3,481
2015-05-26 2015-05-26 B Purchase Ross Julian T

CEO

Executive Director Large shareholder
15,000 +0.1%
0.67
US$10,042 		15,000 +0.1% 0.67 US$10,042
2015-05-26 2015-05-26 B Purchase Ross Julian T

CEO

Executive Director Large shareholder
2,800 +2.0%
0.67
US$1,875 		2,800 +2.0% 0.67 US$1,875
2013-02-13 2013-02-11 S Sale Ross Julian T

CEO, PRESIDENT, SECRETARY

Executive Director Large shareholder
50,000 -0.3%
0.63
US$31,500 		50,000 -0.3% 0.63 US$31,500
Explore more

More insider trading research around OxySure Therapeutics Inc

More insider trades in United States
Insider trading in North America